MET and glioblastoma: Most MET404 KI mice had developed brain tumours at 20 weeks (displayed central nervous system symptoms including paralysis, seizure and/or ataxia), and the tumour phenotypes were very similar to those of GBM, with highly activated MET signalling (Fig. 4d, e).